Clinical Trials Logo

Primary Hypercholesterolemia clinical trials

View clinical trials related to Primary Hypercholesterolemia.

Filter by:

NCT ID: NCT03571087 Completed - Clinical trials for Primary Hypercholesterolemia

Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia

Start date: September 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of HL140 in patients with primary hypercholesterolemia.

NCT ID: NCT03516955 Completed - Clinical trials for Primary Hypercholesterolemia

Efficacy and Safety of a Generic Rosuvastatin in a Real-world Setting

Start date: November 2014
Phase:
Study type: Observational

This study assessed the safety and efficacy of generic Rosuvastatin in reducing plasma low density lipoprotein (LDL) cholesterol in Lebanese adult patients (18 years or older) with dyslipidemia for both primary and secondary prevention based on their total cardiovascular risk. No visits or interventions, additional to the routine clinical practice, were requested or performed.

NCT ID: NCT03464682 Active, not recruiting - Clinical trials for Primary Hypercholesterolemia

Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia

HS-25-C-01
Start date: February 28, 2015
Phase: Phase 3
Study type: Interventional

To determine the efficacy of the HS-25 (10mg or 20mg) or in combination with Atorvastatin (10mg)in reducing low density lipoprotein-cholesterol (LDL-C) levels after a 12-week period of treatment in adults with primary hypercholesterolemia; To determine the safety of HS-25 (10mg or 20mg) or in combination with Atorvastatin (10mg)in subjects with LDL-C after a 40-week period of treament.

NCT ID: NCT03433755 Terminated - Clinical trials for Primary Hypercholesterolemia

Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia

Start date: May 9, 2019
Phase: Phase 3
Study type: Interventional

This study is being done to learn more about evolocumab in Chinese people with primary hypercholesterolemia or mixed dyslipidemia. This study will see if evolocumab will reduce low density lipoprotein cholesterol (LDL-C) in Chinese people who are also taking a certain type of lipid-lowering medication (statins with or without ezetimibe) and whether it causes any side effects.

NCT ID: NCT03413462 Completed - Clinical trials for Primary Hypercholesterolemia

Efficacy and Safety Study of HS-25 in Chinese Adults With Primary Hypercholesterolemia

HS-25-III-01
Start date: April 12, 2016
Phase: Phase 3
Study type: Interventional

To determine the efficacy of HS-25 (20mg) in reducing low density lipoprotein-cholesterol (LDL-C) levels after a 12-week period of treatment in adults with primary hypercholesterolemia; To determine the safety of HS-25 (20mg) in subjects with LDL-C

NCT ID: NCT02941848 Completed - Clinical trials for Primary Hypercholesterolemia

Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers

Start date: November 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate Pharmacokinetic Properties and Safety after administration of HCP1306 tablet and Co-administration of HGP0816 tablet, HGP1404 tablet in the healthy adults.

NCT ID: NCT02445352 Completed - Clinical trials for Primary Hypercholesterolemia

Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia

ROSE
Start date: July 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of DP-R207 in patients with primary hypercholesterolemia.

NCT ID: NCT02205606 Completed - Clinical trials for Primary Hypercholesterolemia

Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia

Start date: June 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of HCP1306 in patients with primary hypercholesterolemia.

NCT ID: NCT02087917 Completed - Clinical trials for Primary Hypercholesterolemia

A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia

Start date: March 2014
Phase: Phase 2
Study type: Interventional

To determine the efficacy of HS-25 (5, 10, 20 or 30 mg) in reducing low density lipoprotein-cholesterol (LDL-C) levels after a 4-week period of treatment in adults with primary hypercholesterolemia.

NCT ID: NCT02009787 Recruiting - Clinical trials for Primary Hypercholesterolemia

Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia

Start date: December 2013
Phase: N/A
Study type: Interventional

The investigators planned to research the effect of vitamin D supplementation as an adjuvant therapy for patients with hypercholesterolemia.